GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.
- DOI
- 10.1111/dom.71065
- Published
- 2026 Sep
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.71065,
title = {GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.},
author = {Park J and Kim JH and Kim YS and Lim G and Song HJ and Rhee SY and Hwang S and Cho D and Kim M and Kim BY and Jeong CW and Kim DY and Park HA and Kim MH and Kim SH and Seo WW and Kim WJ and Suh YS and Park RW and Shin JY},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.71065},
url = {https://doi.org/10.1111/dom.71065}
}RIS
TY - JOUR TI - GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study. AU - Park J AU - Kim JH AU - Kim YS AU - Lim G AU - Song HJ AU - Rhee SY AU - Hwang S AU - Cho D AU - Kim M AU - Kim BY AU - Jeong CW AU - Kim DY AU - Park HA AU - Kim MH AU - Kim SH AU - Seo WW AU - Kim WJ AU - Suh YS AU - Park RW AU - Shin JY PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.71065 UR - https://doi.org/10.1111/dom.71065 ER -
APA
J, P., JH, K., YS, K., G, L., HJ, S., SY, R., S, H., D, C., M, K., BY, K., CW, J., DY, K., HA, P., MH, K., SH, K., WW, S., WJ, K., YS, S., RW, P., & JY, S. (2026). GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71065
Source records
- pubmed · retrieved 2026-09-26T08:10:08.981Z
- europe-pmc · retrieved 2026-09-26T08:10:09.002Z